Format

Send to

Choose Destination
Hematol Oncol. 2020 Feb 19. doi: 10.1002/hon.2725. [Epub ahead of print]

Genetics and epigenetics of leukemia and lymphoma: from knowledge to applications, meeting report of the Josep Carreras Leukaemia Research Institute.

Author information

1
Lymphocyte Development and Disease Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Spain.
2
Lymphoid neoplasms Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Spain.
3
Acute lymphoblastic leukemia (ALL) Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Spain.
4
Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Spain.
5
Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain.
6
Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.
7
Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Spain.

Abstract

The meeting, which brought together leading scientists and clinicians in the field of leukemia and lymphoma, was held at the new headquarters of the Josep Carreras Leukaemia Research Institute (IJC) in Badalona, Catalonia, Spain, September 19-20, 2019. Its purpose was to highlight the latest advances in our understanding of the molecular mechanisms driving blood cancers, and to discuss how this knowledge can be translated into an improved management of the disease. Special emphasis was placed on the role of genetic and epigenetic heterogeneity, and the exploitation of epigenetic regulation for developing biomarkers and novel treatment approaches.

KEYWORDS:

DNA methylation; epi genetics; genetics; leukemia; lymphoma; meeting report

PMID:
32073154
DOI:
10.1002/hon.2725

Supplemental Content

Loading ...
Support Center